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Purpose: Aqueous humor is intimately related to the cells of the anterior and posterior chambers, which affect its
composition. Aqueous analysis provides useful information regarding physiological and pathophysiological processes in
the eye. Human aqueous samples are typically less than 100 µl, limiting the usefulness of the analysis with traditional
Enzyme-Linked immunoSorbant Assay (ELISA) techniques. The specific aim of this study was to investigate if whether
large numbers of analytes can be identified in clinically available samples of aqueous humor and to document the
detectability of certain biomarkers in the aqueous.
Methods: We used a technology developed by Luminex xMAP to analyze hundreds of analytes in a small sample. Aqueous
from eight normal and two diabetic patients was analyzed.
Results: Of the 90 analytes evaluated, 52 (57%) were detectable in the normal aqueous. To place these results in biological
context, we analyzed the list of expressed analytes using the MetaCore database. The functional pathways, networks,
biological processes, and disease processes that these analytes represented were identified. Several ocular pathology-
related processes were represented in the aqueous. The detected analytes represented biomarkers of several relevant disease
processes including vascular diseases, arteriosclerosis, ischemia, necrosis, and inflammation. To provide the proof of
principle that the aqueous profile could offer useful information about the pathophysiological processes, we analyzed two
aqueous samples from diabetic patients. These limited samples showed the differences between normal and diabetic
samples, including those relevant to diabetic retinopathy such as vascular endothelial growth factor (VEGF), C reactive
protein, glutathione, and cytokines. Several biomarker groups for disease processes relevant to diabetes were perturbed.
Conclusions: These results demonstrate that multiplex analysis of the aqueous can be a useful tool in screening for any
pathophysiological changes of the ocular environment. Moreover, ocular pathology/pathophysiology-specific Multi-
analyte profiles MAPs can be developed and used to analyze the aqueous.
Aqueous humor, a product of the ciliary process, occupies
the anterior and posterior chambers of the eye. It supplies
nutrients to the nonvascularized cornea, lens, and trabecular
meshwork. It is drained through two major pathways, the
iridocorneal  and  the  uveoscleral  outflows  I  mean  the
constitution of aqueous humor affects the functioning of cells,
and  also  the  functioning  of  cells  affects  the  aqueous
composition.  In  addition,  functional  barriers  between  the
anterior and posterior segments are not strict. The composition
of the aqueous is also likely to be affected by the physiology/
pathophysiology of the retina. Consequently, several growth
factors have been detected in the aqueous humor, and the
composition  of  these  proteins  changes  dramatically  in
different ocular conditions, especially in inflammation and
glaucoma [1,2].
Evaluation of the aqueous composition can be a powerful
tool  in  understanding  the  pathophysiology  and  treatment
response to many ocular conditions. Assessment of cytokines
in uveitis patients revealed the presence of Interleukin (IL)-2,
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6, 10, 12, Interferon (IFN)-γ, tumor growth factor (TGF)-β2,
tumor necrosis factor (TNF)-α, and macrophage migration
inhibitory factor. One major limitation of testing the aqueous
is that only small sample volumes can be obtained from human
eyes. Typically 50-150 µl of aqueous can be obtained from
one  human  eyes,  which  is  barely  sufficient  to  test  a  few
cytokines  using  traditional  ELISA  techniques  including
sequential ELISA. Alternatively, the samples can be pooled,
but this can mask individual patient differences. However,
with  the  introduction  of  flow  cytometric  bead-based
technology, multiple cytokine analytes can now be quantified
simultaneously  and  rapidly  in  individual  samples.  This
technique has better reproducibility and sensitivity than the
traditional  ELISA  [3].  The  cytometric  bead  array  (CBA)
system  has  proven  effective  in  testing  samples  from  cell
culture supernatant, human serum, tears, and nasal lavage
[4]. In this pilot study, we investigated the detectability of an
array of proteins in the aqueous humor obtained from normal
eyes  to  determine  if  this  analysis  could  be  useful  in
understanding  disease  processes  and  treatment  responses
within the eye.
The aim of this study was to investigate whether large
numbers of analytes can be identified in clinically available
aqueous samples. Large numbers of analytes are needed to
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60perform  global  analysis  for  identifying  maps,  networks,
pathways, and disease processes. Such an analysis would be
useful to compare ocular environment in different conditions.
Another aim of this study was to document the detectability
of certain biomarkers in the aqueous.
METHODS
Samples: Aqueous samples were collected from eight non-
diabetic and 2 diabetic patients undergoing cataract surgery.
Aqueous humor (80–100 µl) was withdrawn through a limbal
paracentesis  site  using  a  27  gauge  needle  in  a  tuberculin
syringe. Care was taken to avoid touching intraocular tissues
and to prevent contamination of aqueous samples with blood.
The samples were immediately frozen and stored at −80 °C.
TABLE 1. LIST OF ANALYTES DETECTED IN AQUEOUS.
Number Analyte SwissProt ID Unit
Standard
Average                    deviation
Folds above
detectable
limits
1 Alpha-1 Antitrypsin P01009 mg/ml 0.00274 0.000893 52033.62
2 Adiponectin Q15848 μg/ml 0.01054 0.002623 10.545
3 Alpha-2 Macroglobulin P01023 mg/ml 0.0006 0.000777 2.07352
4 Alpha-Fetoprotein P02771 ng/ml 0.33637 0.072147 3.911337
5 Apolipoprotein A1 P02647 μg/ml 0.72 0.918 22077.51
6 Apolipoprotein CIII P02656 μg/ml 0.023 0.009896 1733.333
7 Apolipoprotein H P02749 μg/ml 0.61937 0.554624 14076.7
8 Beta-2 Microglobulin P61769 μg/ml 0.18121 0.126304 2745.644
9 Complement 3 P01024 mg/ml 0.00161 0.00162 61454.37
10 Cancer Antigen 125 Q14596 U/ml 9.83 11.01929 11.64692
11 Cancer Antigen 19–9 Q9BXJ9 U/ml 0.11567 0.048019 2.351045
12 CD40 P27512 ng/ml 0.03338 0.016927 7.949405
13 C Reactive Protein P02741 μg/ml 0.01163 0.011371 1520.686
14 Endothelin-1 P05305 pg/ml 3.867 1.675357 2.693245
15 EN-RAGE P80511 ng/ml 0.050   10.06
16 Eotaxin P51671 pg/ml 11.737 3.148795 1.431402
17 Erythropoietin P01588 pg/ml 47.02 54.47922 1.416416
18 Ferritin P02792 ng/ml 3.10333 0.5231 443.3333
19 FGF basic P09038 pg/ml 20.66 5.233832 1.054082
20 Fibrinogen P02671 mg/ml 0.00021 0.000133 4374.364
21 G-CSF P09919 pg/ml 1.26   1.26
22 Glutathione S-Transferase P09488 ng/ml 0.86112 0.971832 10.65749
23 Haptoglobin P00739 μg/ml 0.5 0.476 415.6686
24 IgA P24071 μg/ml 0.97 0.85 23278.44
25 IGF-1 P01343 ng/ml 3.7295 4.838829 4.661875
26 IgM P20769 mg/ml 4.82e−5 2.21e−5 638.4106
27 IL-1ra P18510 pg/ml 5.81   1.936667
28 IL-6 P05231 pg/ml 5.81 7.328891 2.381148
29 IL-8 P10145 pg/ml 4.9412 2.029345 7.038818
30 Leptin P41159 ng/ml 0.11360 0.178015 5.514887
31 Lipoprotein (a) P08519 μg/ml 0.0637 0.043628 3.445946
32 MCP-1 P13500 pg/ml 308.87 191.7174 29.69952
33 MIP-1alpha P10147 pg/ml 7.1362 2.41117 2.744712
34 MIP-1beta P13236 pg/ml 21.707 13.95261 2.863786
35 MMP-3 P08254 ng/ml 0.22912 0.227617 5.728125
36 Myoglobin P02144 ng/ml 0.924 0.331162 176
37 PAI-1 P05121 ng/ml 0.62833 0.483399 139.6296
38 Prostatic Acid Phosphatase P15309 ng/ml 0.01419 0.00844 2.075815
39 PAPP-A Q13219 U/ml 0.01645 0.011151 2.223057
40 “Prostate Specific Antigen, Free” P07288 ng/ml 0.0051   1.094421
41 RANTES P13501 ng/ml 0.00233 0.001534 9.668737
42 Serum Amyloid P P02743 μg/ml 0.0096 0.003076 841.7391
43 Stem Cell Factor P21583 pg/ml 20.575 4.99135 1.85027
44 SGOT P17174 μg/ml 1.0505 0.466578 1.411962
45 SHBG P04278 nmol/l 0.1696 0.070577 652.3077
46 Thyroxine Binding Globulin P05543 μg/ml 0.29598 0.26957 4339.993
47 Tissue Factor P13726 ng/ml 0.4732 0.156952 2.813615
48 TIMP-1 P01033 ng/ml 13.742 11.56826 327.5924
49 TNF RII Q92956 ng/ml 0.07006 0.051629 107.7949
50 Thyroid Stimulating Hormone P01215 U/ml 0.0217 0.018148 3.882143
51 VCAM-1 P19320 ng/ml 2.22 1.408971 170.7692
52 VEGF P15692 pg/ml 214.987 91.01978 143.325
Out of 90 analytes evaluated, 52 were detectable in the aqueous samples. These included cytokines, growth factors, cell
adhesion  molecules immunoglobulin, components of immune system, and enzymes. VEGF is especially relevant for studying
the pathobiology of various retinal disorders.
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61Patients  with  other  ocular  or  systemic  diseases  such  as
inflammatory  diseases  were  excluded  from  the  study.
Informed consent was obtained from the patients, and the
research was in compliance with the tenets of the University
of Florida and the Declaration of Helsinki for experiments
involving human tissue.
Multiplex  analysis:  Multiplex  analysis  was  performed  at
Rules-Based  Medicine  (Austin,  TX),  which  uses  Multi-
Analyte  Profiles  (MAPs)  based  on  powerful  Luminex
xMAP® technology to discover biomarker patterns within
very  small  sample  volumes.  The  aqueous  samples  were
thawed  at  room  temperature,  vortexed,  and  then  spun  at
13,000x g for 5 min to remove any precipitates. Maximum
available volume (80–100 µl) was removed and placed into a
master  microtiter  plate  for  MAP  antigen  analysis.  Using
automated pipetting, an aliquot of each sample was introduced
into one of the capture microsphere multiplexes of the human
antigen MAP. The sample and capture microspheres were
thoroughly mixed and incubated at room temperature for 1 h.
Multiplexed cocktails of biotinylated reporter antibodies for
each multiplex were then added robotically and thoroughly
mixed. After this, the mixture was incubated for an additional
hour at room temperature. Multiplexes were developed using
an excess of streptavidin-phycoerythrin solution, which was
thoroughly mixed into each multiplex and incubated for 1 h
at room temperature. The volume of each multiplexed reaction
was reduced by vacuum filtration, and the volume increased
by dilution into a matrix buffer for analysis. Analysis was
performed in a Luminex 100 instrument (Luminex, Austin,
TX),  and  the  resulting  data  stream  was  interpreted  using
proprietary data analysis software (developed at Rules-Based
Medicine and licensed to Qiagen Instruments, Qiagen Inc.,
Valencia, CA). For each multiplex, calibrators and controls
were  both  included  on  each  microtiter  plate.  Eight-point
calibrators were run in the first and last column of each plate,
and three-level controls were included in duplicate. Testing
results were first determined for the high, medium, and low
controls  of  each  multiplex  to  ensure  proper  assay
performance. Unknown values for each of the analytes that
localized  in  a  specific  multiplex  were  determined  using
weighted and non-weighted curve fitting algorithms included
in the data analysis package.
Analysis:  The  value  for  each  analyte  was  obtained  as  a
concentration (example; mg/ml). The values of eight samples
(or less if an analyte could not be analyzed in all samples
because of insufficient quantity of the sample) were averaged
and compared to the sensitivity of the system. An analyte was
considered “detectable” if the levels exceeded the minimal
detectable levels.
The detectable analytes were further analyzed to identify
biological/disease  processes  and  the  involved  pathways/
Figure 1. List of analytes that showed a twofold or more change in
their levels in diabetic aqueous samples when compared to non-
diabetic samples. The figure shows analytes that showed significant
difference (2 fold or more; abscissa) between normal and the diabetic
aqueous. The most prominent decrease was observed in glutathione
S-transferase, and an increase in fibrinogen.
TABLE 2. LIST OF 10 MOST SIGNIFICANT CANONICAL PATHWAYS MAPS REPRESENTED BY DETECTABLE ANALYTES IN NORMAL AQUEOUS SAMPLES.
Number Name p value
1 Immune response _Histamine signaling in dendritic cells 1.098e−7
2 Development_Leptin signaling via JAK/STAT and MAPK cascades 1.194e−7
3 Immune response _Oncostatin M signaling via JAK-Stat in mouse cells 1.335e−6
4 Immune response _Oncostatin M signaling via JAK-Stat in human cells 2.099e−6
5 Immune response _Histamine H1 receptor signaling in immune response 2.881e−6
6 Cell adhesion_ECM remodeling 3.911e−6
7 Immune response _MIF-mediated glucocorticoid regulation 1.501e−4
8 Immune response _IL1 signaling pathway 5.128e−4
9 Immune response _Oncostatin M signaling via MAPK in mouse cells 6.111e−4
10 Immune response _Oncostatin M signaling via MAPK in human cells 7.207e−4
These pathways prominently represent immune and cell adhesion pathways.
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62networks they participated in by using MetaCore™ analysis
software  (GeneGo  Inc.,  St.  Joseph,  MI).  The  manually
annotated  database  includes  over  160,000  human  protein
interactions and metabolic reactions. The whole data set of 52
detectable analytes was imported in MetaCore to build an
analysis of functional ontologies including GeneGo process,
GeneGo  disease  process,  canonical  pathway  maps,  and
networks. Calculation of statistical significance throughout
MetaCore for maps, networks, and processes are based on p
value,  which  are  calculated  based  on  hypergeometric
distribution. P values essentially represent the probability of
particular mapping arising by chance given the numbers of
genes in the set of all genes on maps/networks/processes,
genes on a particular map/network/process, and genes in the
experiment [5]. We used a p value of 0.05 for the cutoff. The
degree of relevance to different categories for the uploaded
data sets is defined by p values, so that the lower p value
obtains higher priority.
The experimental data were input to build networks. The
three  different  scoring  functions  used  to  rank  the  small
subnetworks created by the network building algorithms were
zScore,  gScore,  and  p  value.  The  zScore  ranks  the
subnetworks (within the analyzed network) with regards to
their  saturation  with  genes  from  the  experiment.  A  high
zScore means the network is highly saturated with genes from
the experiment. In other words, it means that relatively larger
number of genes/analytes in a particular network were present
in  the  aqueous  sample.  Each  network  is  comprised  of
canonical pathways. The gScore modifies the zScore based on
the number of canonical pathways used to build the network.
If a network has a high gScore, it is saturated with expressed
genes  (from  the  zScore),  and  it  contains  many  canonical
pathways.
RESULTS
General analysis: A total of 90 predetermined analytes were
analyzed. All 90 analytes could be analyzed in at least one
sample from normal patients. In normal samples, 57% (52 out
of 90) of the analytes were detectable (above the sensitivity
of the method), and 42% of analytes (38 out of 90) were
undetectable  either  because  their  values  were  below  the
sensitivity of the method (28 out of 90; 31%) or their quantities
were insufficient to assign a value (10 out of 90; 11%). A list
of detectable proteins is provided in Table 1.
Figure  2.  Distribution  by  canonical
pathway maps in order of significance
and their perturbation in diabetics. This
figure shows canonical pathway maps,
in  order  of  significance  and  their
perturbation  in  diabetics.  Relevant  to
diabetes, the immune response and cell
adhesion  pathways  were  notably
perturbed.  Some  pathways  have  been
worked out in mouse cells and this is
noted. The set of common analytes to
both  experiments  is  marked  as  blue/
white stripes. The unique analytes are
marked  as  colored  bars
(orange=diabetic,  blue=normal/non-
diabetic).
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64The  detected  analytes  were  evaluated  by  MetaCore
software to identify possible relations among proteins. The
accession numbers (SwissProt IDs) for the analytes in Table
1 were identified and uploaded into the MetaCore software.
This  software  generates  networks  based  on  interactions
between  uploaded  proteins  and  all  others  proteins/genes
stored  in  the  knowledge  database.  For  each  network,  the
probability of finding the uploaded proteins in the network by
chance  was  calculated.  The  negative  logarithm  of  the
probability represents how relevant this network was to the
list of uploaded proteins.
Distribution  by  canonical  pathways maps
Canonical pathway maps represent a set of approximately
500 signaling and metabolic maps covering human biology in
a comprehensive way. Of the 52 proteins identified in the
normal aqueous, 35 were present in the MetaCore database on
maps. The 10 most significant canonical pathway maps that
are represented relate to immune response, development, and
cell adhesion (Table 2).
Most relevant networks—The list of detectable analytes
was used to generate biological networks using the Analyze
Networks (AN) algorithm, which is a variant of the shortest
paths  algorithm,  with  main  parameters  of  (1)  relative
enrichment with the uploaded data and (2) relative saturation
of  networks  with  canonical  pathways.  Subnetworks  are
ranked by a p value and gScore and interpreted in terms of
Gene Ontology. All 52 proteins identified were present in the
MetaCore database on networks (Table 3).
Distribution by GeneGo and Gene Ontology processes
—The content of about 110 cellular and molecular processes
is defined and annotated by GeneGo. Each process represents
a preset network of protein interactions characteristic to the
process. Of the 52 proteins identified, 41 were present in the
MetaCore  database  on  GeneGo  processes.  The  top  10
processes  represented  in  the  normal  aqueous  samples  are
given  in  Table  4.  These  processes  mostly  represented
responses  to  stimuli,  immune  processes,  response  to
wounding,  inflammation,  defense  and  stress,  cell
proliferation, and chemotaxis.
Distribution by disease biomarkers
There are over 500 human diseases with gene content
annotated by GeneGo and organized in disease folders, which
are further organized into a hierarchical tree. Certain factors
may affect p value prioritization for diseases. For example,
the gene content may vary greatly between complex diseases
(such as cancers and some Mendelian diseases), and also, the
coverage of different diseases in the literature may be skewed.
Of the 52 proteins identified, 50 were present in the MetaCore
database on diseases. The diseases whose biomarkers were
detectable in the aqueous are relevant conditions of the retina
including  vascular  (together  with  vascular  occlusive  and
cardiovascular diseases), arteriosclerosis, ischemia, necrosis,
and  inflammation.  A  list  of  top  10  disease  processes
represented is given in Table 5.
Comparison  between  non-diabetic  and  diabetic  aqueous
samples:
To provide the proof of principle that functional analysis
of  the  aqueous  using  multiplex  technology  could  provide
useful information and identify differences between normal
and disease conditions, we also performed the analysis on two
diabetic samples. Out of 90 analytes, 44 (49%) were detected
and 33 were not detected (36%). Quantity was not sufficient
to analyze 13 analytes.
The  comparison  identified  significant  differences
between  the  two  groups  with  several  analytes  showing
upregulation  and  downregulation.  Analytes  that  showed
twofold or more changes are shown in Figure 1. There were
analytes uniquely expressed in diabetic or normal samples.
Comparison between processes in non-diabetic and diabetic
aqueous are shown in Table 6. There were also changes in the
canonical pathways (Figure 2). The top 10 most significantly
altered GeneGo processes included the ones that involved cell
adhesion  (platelet-endothelium  leukocyte  interactions,
inflammation, chemotaxis, proliferation [positive regulation],
and signal transduction; Figure 3). The vascular diseases,
infarction, arterial occlusion, ischemia, arteriosclerosis, and
TABLE 4. LIST OF 10 MOST STATISTICALLY SIGNIFICANT GENEGO PROCESSES REPRESENTED BY DETECTABLE
ANALYTES IN NORMAL AQUEOUS SAMPLES.
Number Process p value
1 Response to external stimulus 1.63e−11
2 Response to stimulus 2.9e−11
3 Immune system process 2.41e−9
4 Response to wounding 1.02e−8
5 Inflammatory response 1.04e−7
6 Defense response 1.36e−7
7 Immune response 3.86e−7
8 Response to stress 6.83e−7
9 Positive regulation of cell proliferation 7.37e−6
10 Chemotaxis 1.47e−5
Some  of  these  processes,  such  as  response  to  stress,
chemotaxis,  regulation of cell proliferation, wound healing,
and  immune  system  processes,  are  relevant   in  ocular
diseases.
TABLE 5. LIST OF 10 MOST STATISTICALLY SIGNIFICANT DISEASE BIOMARKERS REPRESENTED BY
DETECTABLE ANALYTES IN NORMAL AQUEOUS SAMPLES.
Number Name p value
1 Vascular Diseases 1.843e−21
2 Arterial Occlusive Diseases 5.575e−21
3 Cardiovascular Diseases 4.352e−20
4 Arteriosclerosis 5.866e−20
5 Necrosis 1.571e−18
6 Ischemia 9.303e−18
7 Myocardial Ischemia 1.746e−16
8 Coronary Disease 1.269e−15
9 Infection 1.637e−15
10 Lung Diseases, Obstructive 2.774e−15
Biomarkers  for  vascular  diseases,  ischemia,  necrosis,  and
infection are highly relevant for ocular pathology.
Molecular Vision 2009; 15:60-69 <http://www.molvis.org/molvis/v15/a6> © 2009 Molecular Vision
65
Functional analysis:
—
—necrosis were the most significant diseases whose biomarkers
were perturbed in diabetes (Figure 4).
DISCUSSION
MAPs are a fully developed and validated technique [6,7].
Rule based medicine's (RBM’s) MAPs measure markers of
cancer, infectious disease, autoimmunity, and cardiovascular
risk (similar to age related macular degeneration [AMD] risk)
as  well  as  hormones,  cytokines/chemokines,  acute  phase
reactants, clotting proteins, growth factors, tissue modeling
factors,  and  other  typical  plasma  proteins  [8].  A
comprehensive  analysis  of  an  individual’s  physiological
status can be obtained by measuring a broad spectrum of
biomarkers using MAPs. Luminex technology performs up to
100  multiplexed,  microsphere-based  assays  in  a  single
reaction vessel by combining optical classification schemes,
biochemical assays, flow cytometry, and advanced digital
signal processing hardware and software.
Multiplex  analysis  has  been  performed  on  aqueous
samples in the past but with smaller numbers of analytes [9,
10]. Our results demonstrate that with this technique around
100 different analytes can be successfully analyzed in small
amounts of aqueous samples and provide base line values for
52 analytes. Many of the detected analytes such as CD40, C
reactive protein, endothelin, basic fibroblast growth factor
(bFGF),  fibrinogen,  glutathione  S-transferase,  matrix
metalloproteinase  (MMP)-3,  tissue  inhibitors  of
metalloproteinases  (TIMP)-1,  and  vascular  endothelial
growth  factor  (VEGF)  are  implicated  in  several  ocular
pathologies, and therefore, their measurement could provide
useful  information  [11-14].  Degradation  of  extracellular
matrix proteins is regulated by MMPs. The activity of MMPs
is in turn regulated by their natural inhibitors, TIMPs. MMPs
and TIMPs play an important role in the pathogenesis of
neovascularization  in  the  retina.  It  is  suggested  that  an
imbalance  between  MMPs  and  TIMPs  leads  to
neovascularization  by  affecting  levels  of  VEGF,  one  of
several genes associated with angiogenesis [15,16]. The role
of VEGF in retinal as well as iris neovascularization is well
established, and anti-VEGF therapy is becoming standard in
the management of retinal neovascularization.
The MAP that we used was not specifically designed for
ocular conditions. However, a specifically designed MAP for
investigating ocular disease processes such as response of
treatment  (e.g.,  intravitreal  injection  of  bevacizumab  or
steroids) can provide valuable and relevant information. It can
also  provide  a  method  for  subclassifying/staging  diseases
based on the pathophysiological processes.
TABLE 6. COMPARISON BETWEEN PROCESSES IN DIABETIC AND NON-DIABETIC AQUEOUS HUMOR.
Number Processes Size Target Pathways p value zScore
Common
1 Locomotory behavior (42.6%), G-protein coupled receptor protein
signaling pathway (51.1%), cell surface receptor linked signal transduction
(66.0%)
50 13 10 8.58e−29 57.35
2 Response to external stimulus (56.2%), response to wounding (47.9%),
response to stimulus (79.2%)
50 14 1 1.73e−31 61.78
3 Lipid transport (29.4%), sterol transport (23.5%), cholesterol transport
(23.5%)
50 12 0 3.44e−27 57.78
4 Immune system process (54.0%), organ development (68.0%), response
to stimulus (74.0%)
50 13 0 8.58e−29 57.35
5 Response to stimulus (75.0%), response to wounding (40.9%), response
to external stimulus (47.7%)
50 7 6 4.60e−14 31.76
Unique for
Diabetes
Samples
1 Response to external stimulus (50.0%), response to wounding (41.3%),
cell surface receptor linked signal transduction (58.7%)
50 4 0 1.33e−11 51.55
2 Taxis (100.0%), chemotaxis (100.0%), locomotory behavior (100.0%) 5 1 0 6.01e−04 40.77
Unique for
Normal
Samples
1 Response to wounding (37.2%), response to stimulus (69.8%),
intracellular signaling cascade (51.2%)
50 8 0 1.68e−21 67.49
2 Response to external stimulus (53.8%), response to wounding (46.2%),
cell surface receptor linked signal transduction (64.1%)
44 5 0 8.36e−13 44.93
3 Cellular di-, tri-valent inorganic cation homeostasis (100.0%), di-, tri-
valent inorganic cation homeostasis (100.0%), cellular cation homeostasis
(100.0%)
27 2 0 3.28e−06 37.72
The table lists the top related processes, the total number of genes in the network (Size), the number of genes in the network
from  the input list (Target) and the number of canonical pathways used to build the network (pathways). The comparison of
diabetic and non-diabetic samples shows several processes listed under unique to diabetes and unique to normal samples changed
in the diabetic and non-diabetic samples.
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66We further analyzed the detected analytes to demonstrate
the  usefulness  of  global  analysis  in  identifying  cellular,
biological, and disease processes to obtain an overall view of
ocular physiology. Analytes represented a large number of
pathways, albeit only a small number of proteins represented
many of these. It should be noted that the MAP we used in
this  study  did  not  represent  all  the  cellular  processes
uniformly. Therefore, our data does not indicate if any cellular
process is more prevalent in aqueous than another. We also
did not make any attempt to compare the extent of any cellular
process represented in the MAP with that expressed in the
aqueous. The results demonstrate that aqueous analysis can
provide  useful  information  about  cellular  and  disease
processes. One of the limitations of using MetacoreTM or any
Figure  3.  Distribution  by  GeneGo
processes in order of significance and
their  perturbation  in  diabetics.  This
figure shows GeneGo processes in order
of significance and their perturbation in
diabetics. Relevant to diabetes, the cell
adhesion, inflammation and chemotaxis
pathways were notably perturbed. The
set  of  common  analytes  to  both
experiments  is  marked  as  blue/white
stripes. The unique analytes are marked
as  colored  bars  (orange=diabetic,
blue=normal/non-diabetic).
Figure  4.  Distribution  by  disease
biomarkers in order of significance and
their  perturbation  in  diabetics.  This
figure  shows  disease  biomarkers  in
order  of  significance  and  their
perturbation in diabetics. As expected in
diabetes,  biomarkers  for  vascular
disease, ischemia and infarction showed
perturbation.  The  set  of  common
analytes to both experiments is marked
as  blue/white  stripes.  The  unique
analytes  are  marked  as  colored  bars
(orange=diabetic,  blue=normal/non-
diabetic).
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67other similar program is that the output is not specific for
ocular  diseases.  Output  of  our  results  included  disease
processes such as myocardial infarction and cardiovascular
diseases.  It  is  because  the  program  outputs  any  disease
processes  where  the  input  analytes  participate.  Therefore,
these results should be interpreted in the context of ocular
physiology.  At  a  molecular  level,  aqueous  analysis  could
identify  the  canonical  pathways  and  the  associated  gene
networks. The MAP used in this study did not include analytes
uniformly across all the cellular/disease processes. Therefore,
the data cannot be taken as a representation of these processes
in physiological/pathological conditions. Nevertheless, our
results  demonstrate  that  the  functional  processes  can  be
studied  using  this  technology.  Moreover,  application  of
specific MAPs can be created to suit specific needs.
Another  potential  use  of  such  an  analysis  could  be
comparing two samples for a global view of changes in the
functional processes associated with the ocular environment.
Such  information  may  be  useful  in  understanding  the
pathobiology of a disease, assessing progression of a disease,
or response to a treatment. The analysis of diabetic samples
provided proof of principle for this hypothesis. The aqueous
from diabetic patients showed differences in expected and
relevant cellular as well as disease processes. Some processes
relevant to diabetic retinopathy were found upregulated in
diabetic aqueous samples including CD40, C reactive protein,
erythropoietin,  fatty  acid  binding  protein,  FGF  basic,
fibrinogen,  IL-1ra,  IL-8,  leptin,  macrophage-derived
chemokine  (MDC),  MMP-2,  and  VEGF  [17,18].  Equally
relevant for diabetic pathophysiology were creatine kinase-
MB, glutathione S-transferase, SGOT, and TNF-β, and they
were downregulated in the diabetic aqueous samples [19,20].
It should be noted that since only two diabetic samples were
used,  changes  observed  in  specific  analytes  may  not  be
conclusive.  Larger  sample  sizes  need  to  be  compared  to
confirm conclusions. However, this study suggests multiplex
analysis may be a valuable global screening technique to
identify pathways that warrant further investigation.
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